FDA Warning Letter Trends for Control Testing Laboratories
Stay ahead of regulatory risks with this insightful webinar as it uncovers the most-cited FDA observations in Warning Letters over the past five years—focusing on control testing laboratories. Learn which systems pose the highest risks to your business and how to maintain an inspection-ready laboratory.
Our guest speaker, Constance Fears, will discuss topics including the most common FDA citations for control testing labs, systems and processes with high non-compliance risk, and FDA intelligence software and AI-driven insights to identify trends and mitigate risks.
This webinar is essential for quality assurance (QA) professionals, compliance officers, and laboratory managers striving to align with FDA expectations and safeguard their operations. Don’t miss this opportunity to strengthen your compliance strategies with the latest trends and tools!
- Understand the top-cited FDA observations and their impact on control testing labs.
- Learn how to proactively address high-risk systems to ensure compliance.
- Gain actionable insights into using AI-driven intelligence tools for regulatory readiness.
- Develop strategies to prepare for inspections and avoid common pitfalls.
